Home/Filings/4/0001144204-18-022972
4//SEC Filing

Kraus Al 4

Accession 0001144204-18-022972

CIK 0001175151other

Filed

Apr 26, 8:00 PM ET

Accepted

Apr 27, 11:45 AM ET

Size

8.0 KB

Accession

0001144204-18-022972

Insider Transaction Report

Form 4
Period: 2018-03-15
Kraus Al
Director
Transactions
  • Award

    Stock Option (right to buy)

    2018-03-15+28,87528,875 total
    Exercise: $7.90Exp: 2028-03-15Common Stock (28,875 underlying)
  • Award

    Common Stock

    2018-03-15+3,300125,046 total
Footnotes (3)
  • [F1]These shares represent restricted stock units and will be settled into common stock upon vesting upon a "Change in Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan").
  • [F2]Includes (a) the following restricted stock units subject to vesting in accordance with the schedule set forth in (1) above: (i) 3,300 restricted stock units granted on March 15, 2018 and reported on this Form 4, (ii) 6,000 restricted stock units granted on February 24, 2017, (iii) 5,000 restricted stock units granted on June 7, 2016, and (iv) 55,000 restricted stock units granted on April 8, 2015, and (b) 55,746 shares of common stock owned by the reporting person.
  • [F3]Such options were granted pursuant to the Plan and vest in four equal parts at the end of each calendar quarter beginning January 1, 2018.

Issuer

Cytosorbents Corp

CIK 0001175151

Entity typeother

Related Parties

1
  • filerCIK 0001368152

Filing Metadata

Form type
4
Filed
Apr 26, 8:00 PM ET
Accepted
Apr 27, 11:45 AM ET
Size
8.0 KB